GSK PLC's ticker is and the CUSIP is 37733W204. A total of 858 filers reported holding GSK PLC in Q2 2024. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $19,558 | -10.2% | 508 | 0.0% | 0.01% | -16.7% |
| Q1 2024 | $21,778 | +15.7% | 508 | 0.0% | 0.01% | +20.0% |
| Q4 2023 | $18,827 | +2.2% | 508 | 0.0% | 0.01% | 0.0% |
| Q3 2023 | $18,415 | +1.7% | 508 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $18,106 | +0.2% | 508 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $18,075 | +1.3% | 508 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $17,851 | +19.0% | 508 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $15,000 | – | 508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 13,993,208 | $497,808 | 52.84% |
| Eversept Partners, LP | 3,731,499 | $133,929,238 | 9.34% |
| Camber Capital Management LP | 4,600,000 | $163,668 | 5.03% |
| Callodine Capital Management, LP | 450,000 | $16,011,000 | 4.72% |
| EQUITY INVESTMENT CORP | 3,300,231 | $117,422,219 | 3.85% |
| Robinson Value Management, Ltd. | 128,939 | $4,587,650 | 3.52% |
| Hillman Capital Management, Inc. | 237,416 | $8,447,261 | 3.20% |
| Keystone Financial Planning, Inc. | 262,982 | $9,356,885 | 3.18% |
| Clean Yield Group | 198,160 | $7,050,533 | 3.00% |
| CLIFFORD CAPITAL PARTNERS LLC | 266,755 | $9,491,143 | 2.92% |